Amoxicillin
Product Images NDC 50090-0711

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 9 technical images submitted to the FDA as part of the official labeling for Amoxicillin (NDC 50090-0711). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by A-s Medication Solutions, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Table 1 (Amoxicillin 875 Hikma 1)

Table 1 (Amoxicillin 875 Hikma 1)
A dosing recommendations table for Amoxicillin in adult and pediatric patients over 3 months old, covering infections including ear, nose, throat, skin, genitourinary tract, lower respiratory tract, and gonorrhea. It details usual adult doses, pediatric doses by weight, and notes specific contraindications and dosing guidelines.*
FDA Label Image

Chemical Structure (Amoxicillin 875 Hikma 2)

Chemical Structure (Amoxicillin 875 Hikma 2)
Chemical structure of Amoxicillin showing its molecular components, including a beta-lactam ring, a thiazolidine ring, and an aromatic phenol group, as depicted in the diagram.*
FDA Label Image

Table 3 (Amoxicillin 875 Hikma 3)

Table 3 (Amoxicillin 875 Hikma 3)
A data table displaying mean pharmacokinetic parameters of Amoxicillin 400 mg in two forms: 5 mL suspension and 1 chewable tablet. The table presents values for dose, AUC0-∞ (mcg·hr/mL), and Cmax (mcg/mL) with standard deviations in healthy adults, including clarifying notes on administration and measurement timing.*
FDA Label Image

Bacteria (Amoxicillin 875 Hikma 4)

Bacteria (Amoxicillin 875 Hikma 4)
A data table listing bacteria types divided into two columns: Gram-Positive Bacteria and Gram-Negative Bacteria. The Gram-Positive column includes Enterococcus faecalis, Staphylococcus spp., Streptococcus pneumoniae, and alpha and beta-hemolytic streptococci. The Gram-Negative column lists Escherichia coli, Haemophilus influenzae, Neisseria gonorrhoeae, Proteus mirabilis, and Helicobacter pylori.*
FDA Label Image

Table 4 (Amoxicillin 875 Hikma 5)

Table 4 (Amoxicillin 875 Hikma 5)
A data table titled 'Susceptibility Test Interpretive Criteria for Amoxicillin' outlining the minimum inhibitory concentrations (mcg/mL) and disk diffusion zone diameters (mm) for various bacterial species. The table categorizes susceptibility into susceptible, intermediate, and resistant for Enterococcus, Staphylococcus, Streptococci groups, Enterobacteriaceae, Haemophilus influenzae, and Neisseria gonorrhoeae, with additional explanatory footnotes.*
FDA Label Image

Table 5 (Amoxicillin 875 Hikma 6)

Table 5 (Amoxicillin 875 Hikma 6)
A data table titled 'Acceptable Quality Control Ranges for Amoxicillin' listing various bacteria, their ATCC numbers, minimum inhibitory concentration (MIC) ranges in mcg/mL, and disk diffusion zone ranges in millimeters. Bacteria include Escherichia coli, Enterococcus faecalis, Haemophilus influenzae, Staphylococcus aureus, and Streptococcus pneumoniae, with corresponding quality control values.*
FDA Label Image

Table 6 (Amoxicillin 875 Hikma 7)

Table 6 (Amoxicillin 875 Hikma 7)
A data table showing Helicobacter pylori (H. pylori) eradication rates when Amoxicillin is administered as part of a triple therapy regimen. It includes results from two studies with evaluable and intent-to-treat analyses, presenting percentages, 95% confidence intervals, and patient numbers. Footnotes explain analysis criteria related to duodenal ulcers and infection confirmation.*
FDA Label Image

Table 7 (Amoxicillin 875 Hikma 8)

Table 7 (Amoxicillin 875 Hikma 8)
A data table titled 'H. pylori Eradication Rates When Amoxicillin is Administered as Part of a Dual Therapy Regimen.' It presents results from two studies comparing dual therapy eradication rates based on evaluable analysis and intent-to-treat analysis, including confidence intervals and patient numbers. Footnotes explain analysis criteria and patient inclusion details.*
FDA Label Image

Label Image (Lbl500900711)

Label Image (Lbl500900711)
Label for Amoxicillin 875 mg tablets from A-S Medication Solutions. The label displays product NDC 50090-0711-0 and includes storage instructions to store at 68-77 degrees Fahrenheit. The package contains 20 tablets and notes that each tablet contains amoxicillin trihydrate equivalent to 875 mg amoxicillin. The label also includes a QR code and manufacturer details.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.